Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 270 of 1,261
  1. US 11306150

    Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist

    Five Prime Therapeutics, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  2. US 11306149

    Anti-CD40 antibodies and uses thereof

    CytomX Therapeutics, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  3. US 11306148

    Anti-NPR1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  4. US 11306144

    B7-H4 antibodies and methods of use thereof

    Five Prime Therapeutics, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  5. US 11306155

    Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  6. US 11306131

    T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  7. US 11306130

    PAR3 mimetic peptides and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  8. US 11306123

    Heterotandem bicyclic peptide complex

    BicycleTx Limited · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  9. US 11306121

    Composition for muscle relaxation

    CAREGEN CO., LTD. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  10. US 11306098

    Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

    VENENUM BIODESIGN, LLC · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  11. US 11306095

    Use of pteridinone derivative serving as EGFR inhibitor

    East China University of Science and Technology · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  12. US 11306088

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  13. US 11306104

    Solid state forms of Relugolix

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  14. US 11306077

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  15. US 11305022

    Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders

    The Regents of the University of California · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  16. US 11306115

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    ELOXX PHARMACEUTICALS LTD. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  17. US 11305002

    Compositions and treatments for Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  18. US 11304996

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  19. US 11304980

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  20. US 11304993

    Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

    Rani Therapeutics, LLC · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  21. US 11304988

    Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)

    Northwestern University · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  22. US 11304935

    Use of I-BRD9 or derivatives thereof in preparing anti-epileptic drugs

    University of South China · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  23. US 11304959

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  24. US 11304950

    Methods for treating testicular and ovarian adrenal rest tumors

    SPRUCE BIOSCIENCES, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.